^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anitocabtagene autoleucel (CART-ddBCMA)

    i
    Other names: CART-ddBCMA, ddBCMA T Cell Therapy, KITE-772, anito-cel
    Associations
    News
    Trials
    Company:
    Arcellx, Gilead
    Drug class:
    BCMA-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials